Clinical trial Recruiting at 1 site Observational Ages 18 and up

Macrophage behavior around dental implants in health and peri-implantitis

Official title: Investigation of Macrophage Polarization in Peri-implant Health and Peri-implantitis

Run by Biruni University · NCT07569432 · Data updated 2026-11-12

This study will test whether macrophage-related markers in tissue and fluids around dental implants differ between people with peri-implantitis and those with healthy implants, and whether smoking changes those markers.

More Peri-implantitis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorBiruni University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Istanbul)
StatusRecruiting
StartedDecember 31, 2025
Main results expectedDecember 2027
Study endsSeptember 2028
Registry record updatedOctober 1, 2026
Trial IDNCT07569432 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with at least one bone-level dental implant who meet the 2017 peri-implant disease criteria and are scheduled for exposure surgery are ideal candidates.

Probably not a fit

Patients with prior peri-implant surgery, uncontrolled systemic disease, recent antibiotic or anti-inflammatory use, pregnancy or contraindications to dental surgery are unlikely to be eligible or to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study that will collect peri-implant tissue and fluid samples from adults with and without peri-implantitis who are scheduled for implant exposure surgery. Laboratory measurements will include markers related to macrophage polarization (for example, soluble CD163, BAFF and related cytokines) and characterization of pro-inflammatory (M1) versus anti-inflammatory (M2) profiles. The study will compare marker levels between peri-implantitis cases and controls and perform subgroup analyses by smoking status. Results aim to clarify immune patterns at failing implants that might inform future diagnostics or targeted therapies.

Why it matters

Potential benefit: If successful, this could identify immune markers that help guide earlier or more targeted treatments to preserve dental implants.

How similar studies have gone: Prior studies suggest smoking alters macrophage polarization and that markers like sCD163 and BAFF relate to periodontal inflammation, but data specifically linking these markers to peri-implantitis are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals who is suitable for the peri-implantitis diagnosis according to the classifications of periodontal and peri-implant diseases and conditions established in 2017.
* Individuals with at least one bone-level dental implant and scheduled to undergo exposure surgery.

Exclusion Criteria:

* prior peri-implantitis surgery
* being diagnosed with autoimmune disease, genetic disorders, bone metabolism disorders, poorly controlled systemic diseases (such as diabetes or hypertension)
* pregnancy or lactation
* having a history of oral malignancy, chemotherapy or radiotherapy
* use of anti-inflammatory drugs within 2 weeks, antibiotics within 3 months,
* need for prophylactic antibiotics
* contraindications for dental/surgical procedures.

Where it's running

  • Biruni University
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Ayse Kaban — Biruni University

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • How Smoking Affects Immune Responses Around Dental Implants

    This study tests how smoking changes the body's immune response around dental implants in people with healthy implants, peri-implant mucositis, or peri-implantitis.

    Recruiting Gazi University · Ankara, Ankara · NCT07750171

  • AmbiJet-assisted treatment for inflamed dental implants

    This study tests whether applying cold atmospheric plasma with the AmbiJet system after standard cleaning helps reduce inflammation around dental implants more quickly in adults with peri-implant mucositis or peri-implantitis.

    Recruiting Freiburger Medizintechnik GmbH · Romny · NCT07722715

  • Non-surgical H42 treatment for peri-implant pockets

    This study tests whether H42 can help heal peri-implant pockets compared with no-H42 care in adults with 6–8 mm pockets.

    Recruiting Bioteck S.p.A. · Seville · NCT07680491

  • Access to probing around dental implants

    This multicenter study tests whether limited access to peri-implant probing is linked to more bone loss around dental implants in adults with implants in use for at least three years.

    Recruiting at 9 sites Arrow Development · A Coruña, A Coruña and 8 other locations · NCT07557459

  • Two surgical treatments for peri-implantitis: implantoplasty versus mechanical debridement

    This tests whether adding implantoplasty to resective surgery reduces inflammation and improves outcomes around dental implants in adults with peri-implantitis.

    Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07550127

  • Keratinized mucosa graft to support treatment of peri-implantitis

    This trial will try adding a free gingival graft to non-surgical peri-implantitis care to see if increasing keratinized mucosa helps patients with less than 2 mm of mid‑buccal keratinized tissue heal better.

    Recruiting Gazi University · Ankara · NCT07471386

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.